The Future of HIV Care: Innovative Treatment Strategies

881
Total downloads
8,189
Total views and downloads

Participate in this topic

Articles

ORIGINAL RESEARCH

Published on 12 Dec 2025

Marginal structural Cox model for estimating the effect of Chinese medicine on the survival of people living with HIV: a 17-year real-world retrospective cohort study

Wanqi Pan
Qianlei Xu
Yanmin Ma
Liran Xu
Huangchao Jia
Dongli Wang
Keying Zhu
Miao Zhang
Juan Wang
1 more
Yantao Jin

doi 10.3389/fpubh.2025.1722889

260 views

ORIGINAL RESEARCH

Accepted on 08 Dec 2025

HIV-1 drug resistance and genetic clustering among ART-treated individuals with virologic failure in Aksu, China

Zhenzhen Dai
Hu LI
Mingyu Xu
Jiangtao Feng
Liwen Sun
Di Lu
Yuxue Bi

SYSTEMATIC REVIEW

Accepted on 26 Nov 2025

Evaluating the Efficacy of Digital Health Interventions in Advancing HIV Pre-Exposure Prophylaxis and Therapeutic Adherence Among Transgender Populations: A Systematic Review and Meta-Analysis

Alex Siu Wing Chan
Rayner Kay Jin Tan Tan
Alston Choong
Kean Chang Phang
Sijia Li
Rongrong Wu
Patrick Ming-Kuen Tang
Eleanor J. Ong
Jocelyn Cheung
1 more
Phoenix Mo

122 views

ORIGINAL RESEARCH

Published on 24 Oct 2025

Clinical outcomes in the era of test and treat among children living with HIV: a retrospective before/after study in Zambia

Benson M. Hamooya
Simon Mutembo
Lukundo Siame
Matenge Mutalange
Chilala Cheelo
Kingsley Kamvuma
Brian Muyunda
Keith Mweebo
Nzali Kancheya
8 more
Sepiso K. Masenga

doi 10.3389/fped.2025.1480705

901 views

ORIGINAL RESEARCH

Published on 04 Aug 2025

Unique genetic signatures in HIV-1 subtype A1 and A1D recombinant envelope glycoprotein distinguish contemporary transmitted/founder viruses from historical strains in East Africa

Frank Kato
Anne Kapaata
Ronald Galiwango
Angella Nakyanzi
Christian Ndekezi
Fortunate Natwijuka
Denis Omara
Andrew Ekii Obuku
Brian Foley
2 more
Sheila Nina Balinda

doi 10.3389/fmicb.2025.1632581

2,724 views

ORIGINAL RESEARCH

Published on 30 Jul 2025

Post-marketing safety concerns with dolutegravir: a pharmacovigilance study based on the FDA adverse event reporting system database

Juan Su
Long He
Menglei Wang

doi 10.3389/fphar.2025.1625601

2,189 views

Share on

Frontiers in Microbiology

Virology

Other participating journals

Frontiers in Public Health
- Infectious Diseases: Epidemiology and Prevention
- 3.4 impact factor
- 5.5 citescore

Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.

Impact

8,189Topic views
6,120Article views
881Article downloads

View impact

Articles

Marginal structural Cox model for estimating the effect of Chinese medicine on the survival of people living with HIV: a 17-year real-world retrospective cohort study

HIV-1 drug resistance and genetic clustering among ART-treated individuals with virologic failure in Aksu, China

Evaluating the Efficacy of Digital Health Interventions in Advancing HIV Pre-Exposure Prophylaxis and Therapeutic Adherence Among Transgender Populations: A Systematic Review and Meta-Analysis

Clinical outcomes in the era of test and treat among children living with HIV: a retrospective before/after study in Zambia

Unique genetic signatures in HIV-1 subtype A1 and A1D recombinant envelope glycoprotein distinguish contemporary transmitted/founder viruses from historical strains in East Africa

Post-marketing safety concerns with dolutegravir: a pharmacovigilance study based on the FDA adverse event reporting system database

Frontiers in Microbiology

Virology

Other participating journals

Frontiers in Public Health

Infectious Diseases: Epidemiology and Prevention